Skip to main content
ESPR logo
ESPR
(NASDAQ)
Esperion Therapeutics, Inc.
$3.18-- (--)
Loading... - Market loading

Esperion Therapeutics (ESPR) Stock Price & Financial Analysis

Esperion Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.18 - $3.18
52-Week High$4.18
52-Week Low$1.80
Open$3.18
Average Volume (3M)18.55M
Market Cap799.30M
Shares Outstanding251.35M
Price to Sales (P/S)1.91
Price to Book (P/B)-2.60
EV/EBITDA29.21
Revenue (TTM)418.24M
Net Income (TTM)-7.42M
Free Cash Flow (TTM)-18.19M
EPS (TTM)$-0.03
Profit Margin-1.77%
Operating Margin18.12%
50-Day MA$3.14
200-Day MA$3.06
52-Week Change169.49%
Annual Dividend$3.16
Dividend Yield99.37%
Last Dividend Ex-DateJul 13, 2026

Frequently Asked Questions About Esperion Therapeutics

What is the current stock price for ESPR?

As of the latest trading session, ESPR stock trades at $3.18. The 52-week range is $1.80–$4.18, with a day range of $3.18–$3.18.

What is the P/E ratio for ESPR?

The P/E ratio (Price-to-Earnings) for ESPR is shown in the Key Statistics section. This valuation metric helps compare Esperion Therapeutics, Inc. to industry peers.

Does ESPR pay dividends?

Yes, Esperion Therapeutics pays a 99.37% annual dividend yield ($3.16 per share). The last ex-dividend date was 2026-07-13.

What do analysts recommend for ESPR?

Analyst ratings and recommendations for ESPR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ESPR?

Esperion Therapeutics's market capitalization is $799.3M, classifying it as a small-cap company. Esperion Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.